Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish ...

New diagnostic test soon ready for the market

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Swedish life science in political focus

It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Krönika: Collaboration across borders

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

28 projekt delar på 23 miljoner

När Swelife och Medtech4health delar ut pengar från sin första gemensamma utlysning är elva av 28 projekt från Göteborg.

Faster sales but less profits for Probi

The probiotic company increases its turnover, and the net results are twice as large as last year.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Seminar program Biotech Forum

Here is the entire seminar program at Biotech Forum September 28-29th

Hey Klementina Österberg ...

... CEO at GU Holding, which awards SEK 120, 000 to three female entrepreneurs.

Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

Lytix calls in cash

Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.

Diagnostics to deal with new diseases

Maria Brytting at the Swedish Institute for Infectious Disease Control, SMI, will share her experiences from April 2009 when the new influenza A virus, H1N1, wa...

Life science management for hire

Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.